1,153
Views
0
CrossRef citations to date
0
Altmetric
Research Article

Aiming toWards Evidence baSed inTerpretation of Cardiac biOmarkers in patients pResenting with chest pain using Point of Care Testing (WESTCOR-POC): study design

, , , , , , , , , , , , & show all
Article: 2272585 | Received 12 Jun 2023, Accepted 15 Oct 2023, Published online: 31 Oct 2023

References

  • Goodacre S, Cross E, Arnold J, et al. The health care burden of acute chest pain. Heart. 2005;91(2):229–230. doi:10.1136/hrt.2003.027599.
  • Langlo NM, Orvik AB, Dale J, et al. The acute sick and injured patients: an overview of the emergency department patient population at a norwegian university hospital emergency department. Eur J Emerg Med. 2014;21(3):175–180. doi:10.1097/MEJ.0b013e3283629c18.
  • Reichlin T, Hochholzer W, Bassetti S, et al. Early diagnosis of myocardial infarction with sensitive cardiac troponin assays. N Engl J Med. 2009;361(9):858–867. doi:10.1056/NEJMoa0900428.
  • Keller T, Zeller T, Peetz D, et al. Sensitive troponin I assay in early diagnosis of acute myocardial infarction. N Engl J Med. 2009;361(9):868–877. doi:10.1056/NEJMoa0903515.
  • Westwood ME, Armstrong N, Worthy G, et al. Optimizing the use of High-Sensitivity troponin assays for the early rule-out of myocardial infarction in patients presenting with chest pain: a systematic review. Clin Chem. 2021;67(1):237–244. doi:10.1093/clinchem/hvaa280.
  • Twerenbold R, Costabel JP, Nestelberger T, et al. Outcome of applying the ESC 0/1-hour algorithm in patients With suspected myocardial infarction. J Am Coll Cardiol. 2019;74(4):483–494. doi:10.1016/j.jacc.2019.05.046.
  • Sun BC, Hsia RY, Weiss RE, et al. Effect of emergency department crowding on outcomes of admitted patients. Ann Emerg Med. 2013;61(6):605–611 e6. doi:10.1016/j.annemergmed.2012.10.026.
  • Jones S, Moulton C, Swift S, et al. Association between delays to patient admission from the emergency department and all-cause 30-day mortality. Emerg Med J. 2022;39(3):168–173. doi:10.1136/emermed-2021-211572.
  • Collet JP, Thiele H, Barbato E, et al. 2020 ESC guidelines for the management of acute coronary syndromes in patients presenting without persistent ST-segment elevation. Eur Heart J. 2021;42(14):1289–1367. doi:10.1093/eurheartj/ehaa575.
  • Apple FS, Collinson PO, Kavsak PA, et al. Getting cardiac troponin right: Appraisal of the 2020 European Society of Cardiology guidelines for the management of acute coronary syndromes in patients presenting without persistent ST-Segment elevation by the International Federation of Clinical Chemistry and Laboratory Medicine Committee on Clinical Applications of Cardiac Bio-Markers. Clin Chem. 2021;67(5):730–735. doi:10.1093/clinchem/hvaa337.
  • Collinson P, Suvisaari J, Aakre KM, et al. How well do laboratories adhere to recommended guidelines for cardiac biomarkers management in Europe? The CArdiac MARker guideline uptake in Europe (CAMARGUE) study of the european federation of laboratory medicine task group on cardiac markers. Clin Chem. 2021;67(8):1144–1152. doi:10.1093/clinchem/hvab066.
  • Chew DP, Lambrakis K, Blyth A, et al. A randomized trial of a 1-Hour troponin T protocol in suspected acute coronary syndromes: the rapid assessment of possible acute coronary syndrome in the emergency department With High-Sensitivity troponin T study (RAPID-TnT). Circulation. 2019;140(19):1543–1556. doi:10.1161/CIRCULATIONAHA.119.042891.
  • Anand A, Lee KK, Chapman AR, et al. High-Sensitivity cardiac troponin on presentation to rule Out myocardial infarction: a Stepped-Wedge cluster randomized controlled trial. Circulation. 2021;143(23):2214–2224. doi:10.1161/CIRCULATIONAHA.120.052380.
  • Apple FS, Schulz K, Schmidt CW, et al. Determination of sex-specific 99th percentile upper reference limits for a point of care high sensitivity cardiac troponin I assay. Clin Chem Lab Med. 2021;59(9):1574–1578. doi:10.1515/cclm-2021-0262.
  • Chan PS, Jones PG, Arnold SA, et al. Development and validation of a short version of the seattle angina questionnaire. Circ Cardiovasc Qual Outcomes. 2014;7(5):640–647. doi:10.1161/CIRCOUTCOMES.114.000967.
  • Pettersen KI, Veenstra M, Guldvog B, et al. The patient experiences questionnaire: development, validity and reliability. Int J Qual Health Care. 2004;16(6):453–463. doi:10.1093/intqhc/mzh074.
  • Ware J, Jr., Kosinski M, Keller SD. A 12-Item Short-Form health survey: construction of scales and preliminary tests of reliability and validity. Med Care. 1996;34(3):220–233. doi:10.1097/00005650-199603000-00003.
  • Blinkenberg J, Pahlavanyali S, Hetlevik O, et al. General practitioners’ and out-of-hours doctors’ role as gatekeeper in emergency admissions to somatic hospitals in Norway: registry-based observational study. BMC Health Serv Res. 2019;19(1):568. doi:10.1186/s12913-019-4419-0.
  • High-Sensitivity* Cardiac Troponin I and T Assay Analytical Characteristics Designated by Manufacturer. IFCC Committee on Clinical Applications of Cardiac Bio-Markers (C-CB) v012019. Assessed 2023. https://wwwifccorg/media/477656/high-sensitivity-cardiac-troponin-i-and-t-assay-analytical-characteristics-designated-by-manufacturer-v052022.pdf
  • Apple FS, Smith SW, Greenslade JH, et al. Single High-Sensitivity point-of-Care Whole-Blood cardiac troponin I measurement to rule Out acute myocardial infarction at low risk. Circulation. 2022;146(25):1918–1929. doi:10.1161/CIRCULATIONAHA.122.061148.
  • Collet JP, Thiele H, Barbato E, et al. ESC guidelines for the management of acute coronary syndromes in patients presenting without persistent ST-segment elevation. Rev Esp Cardiol. 2021;74(6):544. 2021
  • Haagensen K, Collinson P, Åsberg A, et al. How does the analytical quality of the High-Sensitivity cardiac troponin T assay affect the ESC rule Out algorithm for NSTEMI? Clin Chem. 2019;65(3):494–496. doi:10.1373/clinchem.2018.298703.
  • Tjora HL, Steiro OT, Langørgen J, et al. Cardiac troponin assays With improved analytical quality: a Trade-Off Between enhanced diagnostic performance and reduced Long-Term prognostic value. J Am Heart Assoc. 2020;9(23):e017465.
  • Tjora HL, Steiro OT, Langørgen J, et al. Diagnostic performance of novel troponin algorithms for the Rule-Out of Non-ST-Elevation acute coronary syndrome. Clin Chem. 2022;68(2):291–302. doi:10.1093/clinchem/hvab225.
  • Thygesen K, Alpert JS, Jaffe AS, et al. Fourth universal definition of myocardial infarction (2018). J Am Coll Cardiol. 2018;72(18):2231–2264. doi:10.1016/j.jacc.2018.08.1038.
  • Steiro OT, Tjora HL, Langorgen J, et al. Clinical risk scores identify more patients at risk for cardiovascular events within 30 days as compared to standard ACS risk criteria: the WESTCOR study. Eur Heart J Acute Cardiovasc Care. 2020;10(3):287–301.
  • Chapman AR, Anand A, Boeddinghaus J, et al. Comparison of the efficacy and safety of early Rule-Out pathways for acute myocardial infarction. Circulation. 2017;135(17):1586–1596. doi:10.1161/CIRCULATIONAHA.116.025021.
  • Nowak RM, Jacobsen G, Limkakeng A, Jr., et al. Outpatient versus observation/inpatient management of emergency department patients rapidly ruled-out for acute myocardial infarction: findings from the HIGH-US study. Am Heart J. 2021;231:6–17. doi:10.1016/j.ahj.2020.10.067.
  • Apple FS. A new season for cardiac troponin assays: it’s time to keep a scorecard. Clin Chem. 2009;55(7):1303–1306. doi:10.1373/clinchem.2009.128363.
  • Collinson PO, Aakre KM, Saenger A, et al. Cardiac troponin measurement At The point Of care: educational recommendations on analytical And clinical aspects by the IFCC committee on cardiac biomarkers (IFCC C-CB). Clin Chem Lab Med. 2023;61(6):989–998. doi:10.1515/cclm-2022-1270.
  • Collinson PO, John C, Lynch S, et al. A prospective randomized controlled trial of point-of-care testing on the coronary care unit. Ann Clin Biochem. 2004;41(Pt 5):397–404. doi:10.1258/0004563041731547.
  • Goodacre SW, Bradburn M, Cross E, et al. The randomised assessment of treatment using panel assay of cardiac markers (RATPAC) trial: a randomised controlled trial of point-of-care cardiac markers in the emergency department. Heart. 2011;97(3):190–196. doi:10.1136/hrt.2010.203166.
  • Loten C, Attia J, Hullick C, et al. Point of care troponin decreases time in the emergency department for patients with possible acute coronary syndrome: a randomised controlled trial. Emerg Med J. 2010;27(3):194–198. doi:10.1136/emj.2008.069427.
  • Renaud B, Maison P, Ngako A, et al. Impact of point-of-care testing in the emergency department evaluation and treatment of patients with suspected acute coronary syndromes. Acad Emerg Med. 2008;15(3):216–224. doi:10.1111/j.1553-2712.2008.00069.x.
  • Ryan RJ, Lindsell CJ, Hollander JE, et al. A multicenter randomized controlled trial comparing Central laboratory and point-of-care cardiac marker testing strategies: the disposition impacted by serial point of care markers in acute coronary syndromes (DISPO-ACS) trial. Ann Emerg Med. 2009;53(3):321–328. doi:10.1016/j.annemergmed.2008.06.464.
  • Bradburn M, Goodacre SW, Fitzgerald P, et al. Interhospital variation in the RATPAC trial (randomised assessment of treatment using panel assay of cardiac markers). Emerg Med J. 2012;29(3):233–238. doi:10.1136/emj.2010.108522.
  • Vestergaard KR, Jespersen CB, Arnadottir A, et al. Prevalence and significance of troponin elevations in patients without acute coronary disease. Int J Cardiol. 2016;222:819–825. doi:10.1016/j.ijcard.2016.07.166.
  • Árnadóttir Á, Vestergaard KR, Pallisgaard J, et al. High-sensitivity cardiac troponin T is superior to troponin I in the prediction of mortality in patients without acute coronary syndrome. Int J Cardiol. 2018;259:186–191. doi:10.1016/j.ijcard.2018.01.131.